PHACTR2: A Potential Drug Target for Tumorigenesis and Metastasis

Target Name: PHACTR2

NCBI ID: G9749

PHACTR2

PHACTR2: A Potential Drug Target for Tumorigenesis and Metastasis

PHACTR2, also known as phosphatase and actin regulator 2, is a protein that plays a crucial role in cellular signaling and cell structure maintenance. PHACTR2 is a member of the PHD2 family, which includes proteins that regulate tyrosination, phosphorylation, and ubiquitination. PHACTR2 is a 21-kDa protein that is expressed in a variety of tissues, including muscle, liver, and brain. It is primarily localized to the endoplasmic reticulum (ER), where it can interact with various signaling molecules, including tyrosine kinases, phosphatidylinositol (PI ) kinases, and ubiquitin.

PHACTR2 functions as a negative regulator of tyrosination and phosphorylation. It can inhibit the activity of the tyrosine kinase Src, which is involved in cell signaling and growth. In addition, PHACTR2 can also inhibit the activity of the PI3K/Akt signaling pathway, which is involved in cell survival and angiogenesis.

PHACTR2 is also involved in the regulation of cell structure and cytoskeletal organization. It can interact with the protein tubulin (MAPT), which is involved in the organization and dynamics of microtubules in the cytoskeleton. PHACTR2 can regulate the activity of MAPT, which is One of the main components of the cytoskeleton, MAPT is responsible for the assembly and disassembly of the cytoskeleton.

In addition, PHACTR2 also interacts with other proteins in cells, including Bcl-2 transcription factor, p21-like transcription factor Rb, p53 tumor suppressor gene, etc. PHACTR2 plays an important role in these interactions and can regulate biological processes such as cell cycle, DNA damage repair, and apoptosis.

PHACTR2 also plays an important role in tumor occurrence and development. PHACTR2 gene mutations can lead to tumorigenesis, especially in bone and muscle tissue. In addition, PHACTR2 is closely related to the metastasis and invasion of tumor cells. Therefore, PHACTR2 is also regarded as a potential tumor target.

PHACTR2 also has great potential in drug development. Since PHACTR2 is a new protein, studying PHACTR2 as a drug target is still of high value. For example, gene editing technology can be used to knock out the PHACTR2 gene, thereby inhibiting the growth and spread of tumor cells. In addition, proteomics technology can be used to screen out compounds with anti-tumor activity, which can be further used in drug development.

In addition, PHACTR2 as a molecule can also serve as a biomarker of disease. For example, PHACTR2 gene expression levels can be used as a predictor of muscle tumors. In addition, PHACTR2 gene knockout can also be used as a therapeutic target for certain cancers.

PHACTR2 is a protein that plays an important role in cell signaling, cell structure maintenance, and tumor development. As a new drug target, PHACTR2 has good prospects and application value.

Protein Name: Phosphatase And Actin Regulator 2

The "PHACTR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHACTR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets